Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001772652-23-000012

Options or other derivatives

  • Chief Technology Officer acquired 81,067 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mertens Steve · Chief Technology Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-11-09 Grant or award : show line 1 in the form Option to Purchase Common Stock +81,067 $1.25 2033-11-08 81,067 81,067 D
Loading xslF345X05/primary_doc.xml…